70. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
Joint Meeting mit der Skandinavischen Gesellschaft für Neurochirurgie
Deutsche Gesellschaft für Neurochirurgie (DGNC) e. V.
12.05. - 15.05.2019, Würzburg
Vorträge Dienstag, 14.05.2019
Gliome klinisch/Gliomas clinical
Meeting Abstract
(V120)
[Full Text]
Contemporary outcome of low grade glioma surgery – results of a prospective multicenter series from the LoG-Glio registry
Coburger J, Roder C, Nadji-Ohl M, Rückriegel S, von der Brelie C, Faust K, Löbel F, Schommer S, Löhr M, Grübel N, Vajcoczy P, Rohde V, Ernestus RI, Ganslandt O, Tatagiba M, Wirtz CR, Pala A[Full Text]
Meeting Abstract
(V121)
[Full Text]
Is less more? Comparison of wait and scan with primary adjuvant treatments in IDH mutant low grade gliomas
Coburger J, Scherer M, Ahmeti H, Roder C, Gessler F, Jungk C, Scheuerle A, Senft C, Tatagiba M, Synowitz M, Schmitz B, Wirtz CR, Unterberg AW, Pala A[Full Text]
Meeting Abstract
(V122)
[Full Text]
Continuous volmetric impact of surgery on survival in low-grade gliomas – a retrospective multicentre assessment from the German study-group for intraoperative MRI
Scherer M, Ahmeti H, Roder C, Geßler F, Senft C, Tatagiba M, Synowitz M, Wirtz CR, Unterberg AW, Coburger J[Full Text]
Meeting Abstract
(V123)
[Full Text]
Complete resection of biological tumor volume in 18F-FET-PET correlates with better overall survival in WHO grade III and grade IV glioma
Hamou H, Tan S, Langen KJ, Neuloh G, Clusmann H, Delev D[Full Text]
Meeting Abstract
(V124)
[Full Text]
Complete versus incomplete resection in newly diagnosed glioblastoma – impact on functional outcome
Haj A, Doenitz C, Schebesch KM, Brawanski A, Proescholdt M[Full Text]
Meeting Abstract
(V125)
[Full Text]
Bevacizumab improves functional status and focal neurological deficits in patients with recurrent glioblastoma
Falter J, Rotter B, Brawanski A, Bumes E, Hau P, Proescholdt M[Full Text]
Meeting Abstract
(V126)
[Full Text]
Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma
Thon N, Fleischmann D, Tonn JC, Kreth FW, Belka C, Niyazi KM[Full Text]
Meeting Abstract
(V127)
[Full Text]
Influence of individual CpG methylation status on outcome in adult patients with glioblastoma multiforme receiving alkylating agent treatment
Siller S, Lauseker M, Giese A, Tonn JC, Niyazi KM, Thon N, Suchorska B, Kreth FW[Full Text]
Meeting Abstract
(V128)
[Full Text]
Central nervous system tumour patients have elevated levels of circulating extracellular vesicles
Ricklefs FL, Maire C, Kolbe K, Holz M, Reimer R, Glatzel M, Chiocca EA, Westphal M, Lamszus K[Full Text]
Meeting Abstract
(V129)
[Full Text]
MiRNA-181d expression significantly affects treatment responses to carmustine wafer implantation in glioblastoma patients
Sippl C, Ketter R, Urbschat S, Kim YJ, Bohr L, Oertel J[Full Text]
Meeting Abstract
(V130)
[Full Text]
Retrospective evaluation of age as an influencing factor for survival in patients with malignant gliomas
Berger K, Mijderwijk HJ, Turowski B, Steiger HJ, Rapp M, Sabel M, Kamp MA[Full Text]
Meeting Abstract
(V131)
[Full Text]
Re-Resection in elderly glioblastoma patients – a reasonable treatment option?
Farina Nunez M, Franco P, Beck J, Heiland DH, Schnell O[Full Text]